Neuroprotection/Neuroprotection (Chichester, England. Print), Journal Year: 2025, Volume and Issue: unknown
Published: May 29, 2025
Highlights Fatiguing syndromes affect millions of patients in the United States and globally, but are grossly underserved clinic contemplative design basic research. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex multisystem metabolic‐immune‐inflammatory disorder. Although research on this condition its infancy, it appears to involve immune system central nervous malfunction, with cellular oxidative stress as predominant feature. Approximately half cases long‐haul coronavirus disease 2019 meet diagnostic criteria for ME/CFS, burgeoning number affected individuals. Recent strides neurobiology have yet transfer understanding neurodegenerative aspects, potential neuroprotection, ME/CFS. ME/CFS may represent useful paradigm model study impact sustained body at large.
Language: Английский